Bringing High Quality Cost-Saving Generic Prescription Medicines to Canadians
Generic drugs can be manufactured after the periods of exclusivity on the brand-name versions have ended. Generic and brand-name drugs have identical active ingredients, and generic drugs must meet Health Canada’s standards for bioequivalence.
The process of bringing a generic prescription medicine to Canadians is complex, requires sophisticated scientific and advanced manufacturing technologies, and can take several years and millions of dollars to complete.
Launching a new prescription medicine requires investments in R&D, product development, testing in clinical trial settings, and the application of innovative and advanced manufacturing processes for Health Canada reviews and approval.